[
  {
    "ts": null,
    "headline": "Big Bank earnings, Fed commentary, tax deadline: What to Watch",
    "summary": "Yahoo Finance host Josh Lipton highlights what to watch on Tuesday, April 15. Earnings reports are expected from Johnson & Johnson (JNJ), Albertsons (ACI), and United Airlines (UAL), as well as major banks like Bank of America (BAC) and Citi (C). Fresh Federal Reserve commentary is coming as Fed Governor Lisa Cook is set to speak. The deadline to file 2024 federal income tax returns is also on Tuesday. To watch more expert insights and analysis on the latest market action, check out more Market Domination Overtime here.",
    "url": "https://finnhub.io/api/news?id=4b2b014ff0323e633781311df7bfb104837ff395fce50ae2458a83a87e39527d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1744671600,
      "headline": "Big Bank earnings, Fed commentary, tax deadline: What to Watch",
      "id": 133917775,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Yahoo Finance host Josh Lipton highlights what to watch on Tuesday, April 15. Earnings reports are expected from Johnson & Johnson (JNJ), Albertsons (ACI), and United Airlines (UAL), as well as major banks like Bank of America (BAC) and Citi (C). Fresh Federal Reserve commentary is coming as Fed Governor Lisa Cook is set to speak. The deadline to file 2024 federal income tax returns is also on Tuesday. To watch more expert insights and analysis on the latest market action, check out more Market Domination Overtime here.",
      "url": "https://finnhub.io/api/news?id=4b2b014ff0323e633781311df7bfb104837ff395fce50ae2458a83a87e39527d"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer hits setback in obesity drug race as GLP-1 trial halts",
    "summary": "Pfizer (PFE) is ending a late-stage trial of its once-daily GLP-1 pill, Danuglipron, after a participant experienced a liver injury. Yahoo Finance Senior Reporter Anjalee Khemlani joins Market Domination Overtime to break down the details, as well as preview what to watch as Johnson & Johnson (JNJ) prepares to report earnings. To watch more expert insights and analysis on the latest market action, check out more Market Domination Overtime here.",
    "url": "https://finnhub.io/api/news?id=c67cc2c67c52b69808250a78258a981296f200d791f326373dd7ba603cb1d69c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1744667089,
      "headline": "Pfizer hits setback in obesity drug race as GLP-1 trial halts",
      "id": 133917776,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Pfizer (PFE) is ending a late-stage trial of its once-daily GLP-1 pill, Danuglipron, after a participant experienced a liver injury. Yahoo Finance Senior Reporter Anjalee Khemlani joins Market Domination Overtime to break down the details, as well as preview what to watch as Johnson & Johnson (JNJ) prepares to report earnings. To watch more expert insights and analysis on the latest market action, check out more Market Domination Overtime here.",
      "url": "https://finnhub.io/api/news?id=c67cc2c67c52b69808250a78258a981296f200d791f326373dd7ba603cb1d69c"
    }
  },
  {
    "ts": null,
    "headline": "Johnson & Johnson Is Beating the Market. Legal Troubles Continue as Earnings Arrive.",
    "summary": "Johnson & Johnson  is scheduled to report its  fiscal first-quarter earnings before markets open on Tuesday, but the company has bigger hurdles to clear than meeting Wall Street’s expectations.  While shares have lagged behind the  for the past three years, J&J remains up 6.7% in 2025 versus the broader market’s 8.1% decline.  Part of the appeal is J&J’s resilience in the face of a potential recession.",
    "url": "https://finnhub.io/api/news?id=877fa21bfd1fde76d11cac4f967c7cd9c1d148b91c17a0e6f0f547980eed6b35",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1744663440,
      "headline": "Johnson & Johnson Is Beating the Market. Legal Troubles Continue as Earnings Arrive.",
      "id": 133917777,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Johnson & Johnson  is scheduled to report its  fiscal first-quarter earnings before markets open on Tuesday, but the company has bigger hurdles to clear than meeting Wall Street’s expectations.  While shares have lagged behind the  for the past three years, J&J remains up 6.7% in 2025 versus the broader market’s 8.1% decline.  Part of the appeal is J&J’s resilience in the face of a potential recession.",
      "url": "https://finnhub.io/api/news?id=877fa21bfd1fde76d11cac4f967c7cd9c1d148b91c17a0e6f0f547980eed6b35"
    }
  },
  {
    "ts": null,
    "headline": "Will more people ride out a trade war with Netflix? The streamer’s results will offer clues.",
    "summary": "Will more people ride out a trade war with Netflix? The streamer’s results will offer clues.",
    "url": "https://finnhub.io/api/news?id=45dc92ee46156ae15f334bde3e2418102fa747c0951bc5c381d0922456a83f78",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1744650300,
      "headline": "Will more people ride out a trade war with Netflix? The streamer’s results will offer clues.",
      "id": 133912199,
      "image": "",
      "related": "JNJ",
      "source": "MarketWatch",
      "summary": "Will more people ride out a trade war with Netflix? The streamer’s results will offer clues.",
      "url": "https://finnhub.io/api/news?id=45dc92ee46156ae15f334bde3e2418102fa747c0951bc5c381d0922456a83f78"
    }
  },
  {
    "ts": null,
    "headline": "Comcast and 5 Other Cheap Stocks That Should Bounce Back Soon",
    "summary": "Comcast and 5 Other Cheap Stocks That Should Bounce Back Soon",
    "url": "https://finnhub.io/api/news?id=95ee447162273f6f03b0908cc5165aa2a6081b60b0fe6a794e3f36480e64707d",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1744648860,
      "headline": "Comcast and 5 Other Cheap Stocks That Should Bounce Back Soon",
      "id": 134146851,
      "image": "",
      "related": "JNJ",
      "source": "MarketWatch",
      "summary": "Comcast and 5 Other Cheap Stocks That Should Bounce Back Soon",
      "url": "https://finnhub.io/api/news?id=95ee447162273f6f03b0908cc5165aa2a6081b60b0fe6a794e3f36480e64707d"
    }
  },
  {
    "ts": null,
    "headline": "Johnson & Johnson (JNJ) Reports Earnings Tomorrow: What To Expect",
    "summary": "Multinational healthcare company Johnson & Johnson (NYSE:JNJ) will be reporting results tomorrow before market open. Here’s what investors should know.",
    "url": "https://finnhub.io/api/news?id=49531b82c5e993ef2c98f15f8130da99f3c394397d3c16989a7e5debbb5875e2",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1744647425,
      "headline": "Johnson & Johnson (JNJ) Reports Earnings Tomorrow: What To Expect",
      "id": 133908230,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Multinational healthcare company Johnson & Johnson (NYSE:JNJ) will be reporting results tomorrow before market open. Here’s what investors should know.",
      "url": "https://finnhub.io/api/news?id=49531b82c5e993ef2c98f15f8130da99f3c394397d3c16989a7e5debbb5875e2"
    }
  },
  {
    "ts": null,
    "headline": "Johnson & Johnson Set to Post Strong Pharma Results in 1Q -- Earnings Preview",
    "summary": "Johnson & Johnson Set to Post Strong Pharma Results in 1Q -- Earnings Preview",
    "url": "https://finnhub.io/api/news?id=0a069c16937834338da32a320de3d307871a8dac1160c9d3a0176ca939e73252",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1744638960,
      "headline": "Johnson & Johnson Set to Post Strong Pharma Results in 1Q -- Earnings Preview",
      "id": 133912482,
      "image": "",
      "related": "JNJ",
      "source": "MarketWatch",
      "summary": "Johnson & Johnson Set to Post Strong Pharma Results in 1Q -- Earnings Preview",
      "url": "https://finnhub.io/api/news?id=0a069c16937834338da32a320de3d307871a8dac1160c9d3a0176ca939e73252"
    }
  },
  {
    "ts": null,
    "headline": "Is Johnson & Johnson (JNJ) the Best Dividend Paying Stock According to Hedge Funds?",
    "summary": "We recently published a list of the 11 Best Dividend Paying Stocks According to Hedge Funds. In this article, we are going to take a look at where Johnson & Johnson (NYSE:JNJ) stands against other best dividend-paying stocks. Dividend-paying stocks have consistently attracted investor interest due to their long-term value. CNBC highlights this by examining […]",
    "url": "https://finnhub.io/api/news?id=5efb46ab1d5573592d1b3c3a011c184de9e1d2fcfc23dc85e37ae9901b37928b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1744638658,
      "headline": "Is Johnson & Johnson (JNJ) the Best Dividend Paying Stock According to Hedge Funds?",
      "id": 133908231,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "We recently published a list of the 11 Best Dividend Paying Stocks According to Hedge Funds. In this article, we are going to take a look at where Johnson & Johnson (NYSE:JNJ) stands against other best dividend-paying stocks. Dividend-paying stocks have consistently attracted investor interest due to their long-term value. CNBC highlights this by examining […]",
      "url": "https://finnhub.io/api/news?id=5efb46ab1d5573592d1b3c3a011c184de9e1d2fcfc23dc85e37ae9901b37928b"
    }
  },
  {
    "ts": null,
    "headline": "J&J: promising results for the OTTAVA robotic system",
    "summary": "Johnson & Johnson has announced that its MedTech division, which specializes in surgical technologies and solutions, has begun the clinical program for the OTTAVA robotic surgical system. A Roux-en-Y...",
    "url": "https://finnhub.io/api/news?id=c9d17116d776690ddb912142437e6ae2772567faf09ef7ed5b8be4017d5bbd8d",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1744619792,
      "headline": "J&J: promising results for the OTTAVA robotic system",
      "id": 133906497,
      "image": "",
      "related": "JNJ",
      "source": "Finnhub",
      "summary": "Johnson & Johnson has announced that its MedTech division, which specializes in surgical technologies and solutions, has begun the clinical program for the OTTAVA robotic surgical system. A Roux-en-Y...",
      "url": "https://finnhub.io/api/news?id=c9d17116d776690ddb912142437e6ae2772567faf09ef7ed5b8be4017d5bbd8d"
    }
  },
  {
    "ts": null,
    "headline": "JPMorgan, Wells Fargo, Morgan Stanley, Netflix, UnitedHealthcare, Johnson & Johnson and CSX Corp are part of Zacks Earnings Preview",
    "summary": "JPMorgan, Wells Fargo, Morgan Stanley, Netflix, UnitedHealthcare, Johnson & Johnson and CSX Corp have been highlighted in this Earnings Preview article.",
    "url": "https://finnhub.io/api/news?id=de32b6b95d6aa5d4699356b99ca08c373e40dac1ea0b3ac4393d8b21ffc195a1",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1744615320,
      "headline": "JPMorgan, Wells Fargo, Morgan Stanley, Netflix, UnitedHealthcare, Johnson & Johnson and CSX Corp are part of Zacks Earnings Preview",
      "id": 133908180,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "JPMorgan, Wells Fargo, Morgan Stanley, Netflix, UnitedHealthcare, Johnson & Johnson and CSX Corp have been highlighted in this Earnings Preview article.",
      "url": "https://finnhub.io/api/news?id=de32b6b95d6aa5d4699356b99ca08c373e40dac1ea0b3ac4393d8b21ffc195a1"
    }
  },
  {
    "ts": null,
    "headline": "Novartis (NVS) Surges 4.0%: Is This an Indication of Further Gains?",
    "summary": "Novartis (NVS) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.",
    "url": "https://finnhub.io/api/news?id=6381cc5f2db38b4b82d7c547ba962a32abaad8c878072b64ac1e6d676dc06831",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1744612200,
      "headline": "Novartis (NVS) Surges 4.0%: Is This an Indication of Further Gains?",
      "id": 133908233,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Novartis (NVS) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.",
      "url": "https://finnhub.io/api/news?id=6381cc5f2db38b4b82d7c547ba962a32abaad8c878072b64ac1e6d676dc06831"
    }
  },
  {
    "ts": null,
    "headline": "US Court Rejects Johnson & Johnson Bankruptcy Bid",
    "summary": "and which were globally discontinued by the company in 2022. Following this latest dismissal - the third rejected proposal brought by a J&J subsidiary in an effort to use the US bankruptcy system to...",
    "url": "https://finnhub.io/api/news?id=415215eaf06b023099622ed2df5e62c3ac2eb796680f868df245d930c88961a8",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1744611126,
      "headline": "US Court Rejects Johnson & Johnson Bankruptcy Bid",
      "id": 133905605,
      "image": "",
      "related": "JNJ",
      "source": "Finnhub",
      "summary": "and which were globally discontinued by the company in 2022. Following this latest dismissal - the third rejected proposal brought by a J&J subsidiary in an effort to use the US bankruptcy system to...",
      "url": "https://finnhub.io/api/news?id=415215eaf06b023099622ed2df5e62c3ac2eb796680f868df245d930c88961a8"
    }
  }
]